Medical Device Company Discloses Potential FCPA Violation
A U.S.-based multinational medical device company said it may have violated the Foreign Corrupt Practices Act. In a May 2 SEC filing, Stryker said it has hired outside counsel to investigate whether “certain business activities in a foreign country violated…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
provisions” of the FCPA, adding that both the SEC and DOJ have contacted it. The company said it’s cooperating with both agencies. “At this time we are unable to predict the outcome of the investigation or the potential impact, if any, on our financial statements,” Stryker said.